NCT05277740View on ClinicalTrials.gov

Implementation of a Novel Functional Eye-Tracking Biomarker for Multiple Sclerosis

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Clinically Isolated SyndromeRelapsing Remitting Multiple Sclerosis
Interventions
DEVICE

Eye-tracking

Eye-tracking technology and algorithms used to successfully capture and track eye movements using an electronic tablet and the embedded camera of the device.

Trial Locations (1)

H3A 2B4

RECRUITING

Montreal Neurological Institute and Hospital, Montreal

Sponsors

Collaborators (1)

Innodem Neurosciences
All Listed Sponsors
collaborator

Innodem Neurosciences

INDUSTRY

lead

McGill University

OTHER